VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Change in Accured Expenses (2010 - 2026)

VivoSim Labs (VIVS) posted quarterly Change in Accured Expenses of $163000.0 for Q1 2026, down 22.75% year-over-year from $211000.0 in Q1 2025, and up 246.81% quarter-over-quarter from $47000.0 in Q4 2025.

VivoSim Labs (VIVS) Change in Accured Expenses (2010 - 2026) Analysis & Trends

VivoSim Labs' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $163000.0 for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 22.75% year-over-year to $163000.0; the TTM figure through Mar 2026 stood at -$245000.0 (down 134.17% YoY), while the FY2026 annual figure was -$245000.0, down 134.17% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at $163000.0, up from $47000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.2 million in Q1 2023, with the low at -$2.1 million in Q2 2023.
  • The 5-year median for Change in Accured Expenses is $54000.0 (2023), against an average of $17062.5.
  • The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses tumbled 2086.36% in 2022, then surged 603.89% in 2023.
  • VivoSim Labs' Change in Accured Expenses stood at $184000.0 in 2022, then tumbled by 66.85% to $61000.0 in 2023, then soared by 480.33% to $354000.0 in 2024, then tumbled by 86.72% to $47000.0 in 2025, then jumped by 246.81% to $163000.0 in 2026.
  • Business Quant data shows VIVS's Change in Accured Expenses at $163000.0 in Q1 2026, $47000.0 in Q4 2025, and $44000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 VivoSim Labs 1.49 Mn 1.49 Mn - -243,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -243,000.00
Jun 30, 2026 -243,000.00
Mar 31, 2026 163,000.00
Mar 31, 2026 163,000.00
Dec 31, 2025 47,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 44,000.00
Sep 30, 2025 44,000.00
Jun 30, 2025 -499,000.00
Jun 30, 2025 -499,000.00
Mar 31, 2025 211,000.00
Mar 31, 2025 211,000.00
Dec 31, 2024 354,000.00
Dec 31, 2024 354,000.00
Sep 30, 2024 475,000.00
Sep 30, 2024 475,000.00
Jun 30, 2024 -323,000.00
Jun 30, 2024 -323,000.00
Dec 31, 2023 61,000.00
Dec 31, 2023 61,000.00